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The incidence of frontal fibrosing alopecia (FFA) appears to be increasing1-6 and response to 
treatment has been largely disappointing1-3. However, assessment of treatment interventions is 
confounded by slow disease progression  and lack of robust means of assessing disease severity and 
activity. To address the latter, we have developed a validated clinical scoring system – the FFA 
severity index (FFASI), which provides a standardised framework for FFA assessment and patient 
stratification.   
A British Hair and Nail Society (BHNS) subgroup considered clinical methods of assessing FFA 
severity and activity. In agreement with other authors4,7, assessment of alopecia band width was 
deemed the most appropriate and objective measurement of severity, with changes in extent over 
time reflecting disease activity. FFASI was compiled in two forms: FFASI  and FFASI B (figure 1). 
FFASI utilises clinical images of the entire hairline, divided into 4 sections. Alopecia severity is graded 
1-5 based on hairline recession similar to criteria proposed by Vano Galvan4.  In order that hairline 
recession comprises the greatest proportion of the assessment, each grade is weighted. Although of 
uncertain significance1,2,8 , frontal band inflammation is also assessed. Non-scalp hair loss5 (eyebrow, 
eyelash, limb and flexural)  are scored, as are associated features (facial papules2,9; cutaneous2,4, 
nail10 and mucosal LP1,2,4; and generalised scalp LPP1,4). Scores for hairline recession, inflammatory 
band, non-scalp loss and associated features may be combined to give a maximum score of 100. 
FFASIB uses the same format but rather than grading alopecia, permits user-defined measurement of 
each hairline section. FFASIB was not validated in this exercise.  
FFASI validation was undertaken by two methods. Firstly, the clinical images used in FFASI were 
evaluated by panel of 11 BHNS consultant dermatologists. Each graded 30 FFA patient photographs 
using FFASI. The exercise was undertaken twice to assess intra-observer agreement.  Secondly, a 
clinical assessment of 3 FFA patients was undertaken by 6 dermatologists (3 consultant 
dermatologists (2 with alopecia special interest), 2 dermatology trainees and a staff grade) using 
FFASI. Each patient was examined on two occasions by each dermatologist. Assessors were 
instructed to grade to the main hairline, not to “lonely” hairs11 and, where band width was not uniform, 
to grade to the most representative image.  Inter and intra-observer agreement were assessed using 
Kendall’s Coefficient of Concordance W. Values range from 0(no agreement) to 1(complete 
agreement) and agreement levels were classified according to Schmidt12 . Where assessment ratings 
resulted in 2 or fewer categories, Kappa statistics were computed. Calculations were performed using 
Minitab(v17).  
For assessment of patient photographs using FFASI, intra-observer concordance showed strong to 
very strong agreement for all hairline areas, indicating consistency in assessments by individual 
consultants (supplementary table 1a). The results of inter-observer agreement indicated overall 
agreement between consultants was very strong, with all values >0.85 for each hairline area 
assessed (supplementary table 1b). Thus, all consultants consistently assessed FFA patient 
photographs using FFASI. In the clinical evaluation, Kendall’s coefficient demonstrated intra-observer 
reliability was very strong for frontal, right, left and posterior hairlines, and frontal band assessments 
(supplementary table 2a).  Scores for flexural hair loss were strong to very strong. Concordance for 
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eyebrow and eyelash scores showed complete agreement however, limb scores showed poorer 
agreement for assessors without an alopecia special interest. The results for inter-observer 
agreement for clinical assessments showed very strong agreement between observers for frontal, 
right and left hairlines and eyebrows (supplementary table 2b). For the posterior hairline and frontal 
band, values were slightly >0.5, indicating moderate agreement. Agreement for eyelash and limb 
assessment was poorer with kappa values 0.037 and 0.345 respectively. However, concordance 
between consultants with an alopecia interest was very strong, suggesting experience in clinical 
assessment resulted in greater consistency.  
We have developed a validated scoring system for FFA assessment. FFASI permits assessment of 
the entire hairline, inflammatory frontal band, facial and body hair loss, and associated features. 
FFASI is weighted in favour of hairline assessment as alopecia is the principle feature. However, a 
total score out of 100 can be calculated, representing global disease severity. Initially considered a 
scalp disorder, both facial and body hair are frequently lost5 and may sometimes predate onset of 
scalp loss4. Facial vellus follicle involvement results in facial papules2,9. Cutaneous, mucosal and nail 
LP, and generalised scalp LPP are infrequently associated1,2,4,10. The natural history is unclear and it 
is uncertain how the condition progresses. Involvement of the frontal hairline seems universal4. Loss 
of eyelashes and facial papules are associated with more severe disease4.  
FFA treatments need to be assessed by clinical trials. Many treatments have been used but as 
evidence is weak (no RCTs, variable outcome measures etc.), it is difficult to assess superiority of 
efficacy7,13. To have confidence in trial results, a standardised, validated and objective assessment 
method is required. To date, several non-standardised and non-validated methods have been used. 
The most frequent method is measurement from nasal crease to frontal hairline or other 
forehead/frontal hairline measures1,2. Although helpful for measuring change in a patient over time, 
this is less helpful when comparing between patients due to differing pre-morbid hairline positions. 
Detailed photographic images are an accurate means of monitoring disease however, they do not 
permit statistical analysis. LPPAI was devised as an assessment tool for LPP activity14. It includes 
scoring of symptoms and signs of inflammation, positive anagen-pull and disease spreading, with 
results calculated using a devised formula. It has been criticised for being based on subjective data 
calculated using an arbitrary formula15, and gives no account of extent of hair already lost. FFASI 
offers a more complete assessment of the hairline than point measurement(s) and provides numerical 
data that can be analysed statistically. It does not rely unduly on measures of uncertain significance 
(symptoms, erythema or anagen-pull), but measures the cardinal disease feature, extent of alopecia. 
Additionally, it allows global disease assessment by including facial and body hair, and associated 
features.   
Change in FFASI grade over time reflects disease activity and the standardised format allows 
comparison between patients. One weakness of FFASI is that it relies upon a “best-fit” model for 
grading alopecia band width: bands of recession are not entirely uniform and clinical judgement is 
required. However, more precise assessment can be made by recording actual band width 
measurements using FFASI B. In conclusion, we have a developed a validated scoring system for 
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FFA which allows global disease assessment for individuals over time and permits comparison 
between patients.  
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